Welcome to the e-CCO Library!

P031 Therapeutic effect of OPS-2071 in a murine model of Crohn’s disease and in in vitro anti-inflammatory assays
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Takagi1, M. Sato1, F. Kazuyuki1, I. Shibuya2, D. Oka1, N. Yamaya3, K. Inagaki1

Created: Thursday, 30 January 2020, 10:12 AM
P031: CKD-506, a new histone deacetylase 6 inhibitor, suppresses immune cells and restores intestinal epithelial function
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lee, J.Y.(1);Ma, H.W.(2);Kim, J.H.(2);Park, I.S.(2);Son, M.(2);Ryu, K.H.(3);Shin, J.(3);Kim, W.H.(4);KimResearch professor, S.W.(2)*;Cheon, J.H.(4);
Created: Friday, 14 July 2023, 10:48 AM
P031: Class A1 scavenger receptor mediates macrophage polarization and apoptotic progression in a murine dextran sulfate sodium-induced colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Su, J.(1);Xie, C.(1);Hu, Y.(1);Huang, Q.(1);Shi, H.(1);Wang, L.(1);Ren, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P031: Effects of tobacco alkaloids on DSS-induced colitis mouse model
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Lo Sasso1*, B. Phillips2, R. Gadaleta1, A. Elamin1, A. Kondylis1, N. Ivanov1, J. Hoeng1

Created: Thursday, 21 February 2019, 9:14 AM
P031: Identification of alternative splicing in transcript isoforms in patients with ulcerative colitis: effects of disease duration
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Low E.N.D.*1, Wong Z.1, Ngiu C.S.1, Nazefah A.H.2, Rafiz A.R.3, Mokhtar N.1, Raja Ali R.A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P031: Impact of nutritional antigens in inflammatory bowel disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Rodríguez Sillke*1, M. Schumann1, D. Lissner1, F. Branchi1, R. Glauben1, B. Siegmund1

Created: Friday, 22 February 2019, 9:41 AM
P031: Intestinal lymphoepithelial interactions in Crohn's disease: modeling alphaE-beta7 and NKG2D blockade
Year: 2022
Source: ECCO'22
Authors: Hammoudi, N.(1);Hamoudi, S.(2);Bonnereau, J.(2);Bottois, H.(2);Perez, K.(2);Bezault, M.(2);Hassid, D.(1);Chardiny, V.(2);Celine, G.(2);Gergaud, B.(2);Bonnet, J.(1);Chedouba, L.(1);Tran Minh, M.L.(1);Gornet, J.M.(1);Baudry, C.(1);Corte, H.(3);Maggiori, L.(3);Toubert, A.(2);McBride, J.(4);Brochier, C.(5);Neighbors, M.(4);Le Bourhis, L.(2);Allez, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P031: STAT6 deficiency alters macrophage polarisation and promotes fibrosis in a murine model of chronic inflammation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Salvador*1, D. Ortiz-Masiá1, D. C. Macias-Ceja1, 2, J. Cosín-Roger1, L. Gisbert-Ferrándiz1, C. Hernández2, S. Calatayud1, M. D. Barrachina-Sancho1

Created: Friday, 22 February 2019, 9:49 AM
P032 has been withdrawn.:
Year: 2018
Source: ECCO '18 Vienna
Authors:

Created: Thursday, 21 February 2019, 9:14 AM
P032 Increased endoplasmic reticulum stress-specific chaperones characterise CD fibrosis epithelium tissues and participate to in vitro induction of intestinal fibrobast differentiation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Vieujean1, S. Hu1, E. Bequet1, C. Salee1, C. Massot1, N. Bletard2, N. Pierre1, F. Quesada calvo1, D. Baiwir3, G. Mazzucchelli4, E. De Pauw4, P. Delvenne2, M.A. Meuwis1, E. Louis1

Created: Thursday, 30 January 2020, 10:12 AM
P032: Distinct immune cell trigger responses in Ulcerative Colitis – Results from an in vivo human intestinal injury model
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bronze, M.(1,2)*;Vilstrup Johansen, J.(3);Attauabi, M.(1);Tveiten Bjerrum, J.(1);Ramírez Galera, M.(2);Woetmann, A.(2);Benedict Seidelin, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P032: Hepatocyte growth factor and MET in ulcerative colitis, novel drug targets impairing neutrophil recruitment?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Verstockt*1,2, M. Stakenborg2, W-J. Wollants2, G. Van Assche1,2, M. Ferrante1,2, S. Vermeire1,2, G. Matteoli2

Created: Friday, 22 February 2019, 9:41 AM
P032: Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients
Year: 2022
Source: ECCO'22
Authors: Ungar, B.(1);Yavzori, M.(1);Fudim, E.(1);Picard, O.(1);Kopylov, U.(1);Eliakim, R.(1);Shouval, D.(2);Levin, Y.(3);Savidor, A.(3);Ben-Moshe, S.(4);Manco, R.(4);Dan, S.(4);Egozi, A.(4);Bahar Halpern, K.(4);Mayer, C.(5);Barshak, I.(5);Ben-Horin, S.(1);Itzkovitz, S.(4);
Created: Friday, 11 February 2022, 3:52 PM
P032: IFN-γ controls the immunomodulatory properties of bone marrow mesenchymal stem cells via a microRNA29a/STAT-3 dependent mechanism
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Oikonomopoulos*1, P. Lacey1, T. Tomakili1, D. Iliopoulos2, 
D. W. Hommes1

Created: Friday, 22 February 2019, 9:49 AM
P032: MiR-511 deficiency aggravates T cell transfer colitis in mice
Year: 2021
Source: ECCO'21 Virtual
Authors: Rahman, S.(1);Elfiky, A.(1);H.P. van Hamersveld, P.(1);Verseijden, C.(1);Welting, O.(1);L Meijer, S.(2);B.M. Hakvoort, T.(1);J. de Jonge, W.(1);E.M. Heinsbroek, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P032: The pharmacological profile of TOP1288, a narrow spectrum kinase inhibitor in clinical development as an anti-inflammatory treatment for ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Foster M.*1, Biancheri P.2, Fyfe M.1, MacDonald T.3, Rowley A.1, Sirohi S.1, Solanke Y.1, Webber S.1, Walshe C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Manzini, K. Atrott, M. Schwarzfischer, A. Laimbacher, S. Lang, G. Rogler, M. Scharl, M.R. Spalinger

Created: Thursday, 30 January 2020, 10:12 AM
P033: Anti-TNF-α therapy normalises aberrant cytokine production and homing profile of circulating dendritic cells in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Hendy*1, 2, D. Reddi2, D. Bernardo3, L. Durant2, A. Noble2, N. English2, S. Knight2, A. Hart1

Created: Friday, 22 February 2019, 9:49 AM
P033: Dendritic cells from patients with active IBD imprint pro-inflammatory α4β7+CLA+ T cells with potential for gut and skin homing
Year: 2021
Source: ECCO'21 Virtual
Authors: Gordon, H.(1);Rodger, B.(1);Hoti, I.(1);Lindsay, J.O.(2);Stagg, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P033: DSS-induced colitis is attenuated in sigma-1 receptor knockout mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lόpez-Estévez S.*1, Aguilera M.1, Gris G.2, de la Puente B.2, Codony X.2, Zamanillo D.2, Martínez V.1

Created: Wednesday, 20 February 2019, 10:36 AM